Login

Orbis' CEO Jani Linna-Aro interviews Phil Stanway from Huber+Suhner AG about their partnership and business insights. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Candles Scandinavia CEO Viktor Garmiani Breaks Down Recent Financial Results | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
synthesize engineering with physical and life sciences to create technologies that disrupt global conventions|Benjamin Quiroga,General Partner,Humboldt Fund
00:10:00
Navigating Grief: Coping with the Loss of a Loved One | Ron Bernstein - Co-Founder and Managing Partner, Prism Planning Partners
00:10:00
Selamat Pagi Malaysia bersama CEO Ranhill SAJ pada 17 Mei 2020, di mana Ketua Pegawai Eksekutif Sr. Tn. Hj. Nor Ifuan Md. berbicara pada awal pagi.
00:10:00
Bredband2: CEO Daniel Krook's interview | Daniel Krook, CEO, Bredband2 i Skandinavien ABBRE2:STO
00:10:00
Navigating Financial Services: Insights from Chris Flowers on Opportunities and Challenges
00:10:00
Rogers Corporation CEO Bruce Hoechner discusses the company's Code of Business Ethics.
00:10:00
Paul Reilly, CEO of Raymond James, Discusses Economic Outlook and Company Strategy Amidst Uncertain Times|  Paul Reilly, CEO , Raymond James.
00:10:00
Invests in technical founders building the next generation of applications|Mike Dauber,General Partner,Amplify Partners
00:10:00
Brickability Group PLC Wins AIM 'Transaction of the Year Award | Alan Simpson - CEO of Brickability Gr
00:10:00
Global Investment Insights: KKR's Market Outlook
00:00:00
Christopher V. DeSimone, M.D., Cardiac Electrophysiologist, Mayo Clinic

© 2026 Nehu